Aim: To evaluate sexual functions of women having stress urinary incontinence (SUI) preoperatively and 6 months and 12 months after undergoing a transobturator tape (TOT) ± pelvic organ prolapse (POP) surgery. Methods: One hundred-ninety-five women with SUI ± POP were recruited and 150 sexually active women who had clinical ± urodynamic SUI and underwent TOT ± POP surgery were included in this prospective study. Urogynecologic symptoms were evaluated preoperatively, at 6 months, and 12 months by Female Sexual Function Index (FSFI). Results: One hundred fifty women completed the study. Seventy-four underwent TOT-only and 76 underwent TOT + concomitant surgery. Mean total scores of FSFI were 21.7 ± 7.8, 22 ± 8.7, and 22.1 ± 8 in the preoperative period, postoperative 6, and 12 months, respectively. There was significant improvement in desire and total scores in the TOT-only group, whereas there was no significant difference in the TOT + concomitant surgery group except for significant worsening in the lubrication domain. The frequency of sexual intercourse increased while that of coital incontinence decreased after surgery. Conclusions: In our study, TOT was associated with decrease in coital incontinence and significant improvement in desire. In addition, there was significant improvement in FSFI desire and total scores in the TOT-only group, whereas no significant difference was observed in the TOT + concomitant surgery group except for the worsening of lubrication.

1.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A: The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-178.
2.
Jha S, Ammenbal M, Metwally M: Impact of incontinence surgery on sexual function: a systematic review and meta-analysis. J Sex Med 2012;9:34-43.
3.
Milsom I, Altman D, Cartwright R, Lapitan MC, Nelson R, Sillén U, Tikkanen K: Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal incontinence (AI), incontinence; In: Abrams P, Cardozo L, Khoury S, Wein A (eds): 5th International Consultation on Incontinence. Paris, SMART-DOT Marketing & Web Consultants 2012, pp 15-107.
4.
Bekker MD, Hogewoning CR, Wallner C, Elzevier HW, DeRuiter MC: The somatic and autonomic innervation of the clitoris; preliminary evidence of sexual dysfunction after minimally invasive slings. J Sex Med 2012;9:1566-1578.
5.
Novara G, Artibani W, Barber MD, Chapple CR, Costantini E, Ficarra V, Hilton P, Nilsson CG, Waltregny D: Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol 2010;58:218-238.
6.
Latthe PM, Foon R, Toozs-Hobson P: Transobturator and retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. BJOG 2007;114:522-531.
7.
Simsek A, Ozgor F, Yuksel B, Kucuktopcu O, Kirecci SL, Toptas M, Sarılar O , Berberoglu AY, Gurbuz ZG, Mimaroglu S, Akbulut F, Baykal M, Arslan B, Savun M, Ucpinar B: Female sexual function after transobturator tape in women with urodynamic stress urinary incontinence. Springerplus 2014;3:570.
8.
Delorme E: [Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women]. Prog Urol 2001;11:1306-1313.
9.
Dursun M, Otunctemur A, Ozbek E, Cakir SS, Polat EC: Impact of the transobturator tape procedure on sexual function in women with stress urinary incontinence. J Obstet Gynaecol Res 2013;39:831-835.
10.
Oksuz E, Malhan S: Reliability and validity of the Female Sexual Function Index in Turkish population. Sendrom 2005;17:54-60.
11.
Wiegel M, Meston C, Rosen R: The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005;31:1-20.
12.
Delorme E, Droupy S, de Tayrac R, Delmas V: Transobturator tape (Uratape): a new minimally-invasive procedure to treat female urinary incontinence. Eur Urol 2004;45:203-207.
13.
Juma S, Brito CG: Transobturator tape (TOT): two years follow-up. Neurourol Urodyn 2007;26:37-41.
14.
Pauls RN, Segal JL, Silva WA, Kleeman SD, Karram MM: Sexual function in patients presenting to a urogynecology practice. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:576-580.
15.
Handa VL, Cundiff G, Chang HH, Helzlsouer KJ: Female sexual function and pelvic floor disorders. Obstet Gynecol 2008;111:1045-1052.
16.
Kingsberg SA, Janata JW: Female sexual disorders: assessment, diagnosis, and treatment. Urol Clin North Am 2007;34:497-506.
17.
Mestre M, Lleberia J, Pubill J, Espuña-Pons M: Questionnaires in the assessment of sexual function in women with urinary incontinence and pelvic organ prolapse. Actas Urol Esp 2015;39:175-182.
18.
Rogers RG, Kammerer-Doak D, Darrow A, Murray K, Qualls C, Olsen A, Barber M: Does sexual function change after surgery for stress urinary incontinence and/or pelvic organ prolapse? A multicenter prospective study. Am J Obstet Gynecol 2006;195:e1-e4.
19.
Stoutjesdijk JA, Vierhout ME, Spruijt JW, Massolt ET: Does vaginal reconstructive surgery with or without vaginal hysterectomy or trachelectomy improve sexual well being? A prospective follow-up study. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:131-135.
20.
Pauls RN, Silva WA, Rooney CM, Siddighi S, Kleeman SD, Dryfhout V, Karram MM: Sexual function after vaginal surgery for pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 2007;197:622.e1-e7.
21.
Dalpiaz O, Kerschbaumer A, Mitterberger M, Pinggera GM, Colleselli D, Bartsch G, Strasser H: Sexual medicine female sexual dysfunction: a new urogynaecological research field. BJU Int 2008;101:717-721.
22.
Pace G, Vicentini C: Female sexual function evaluation of the tension-free vaginal tape (TVT) and transobturator suburethral tape (TOT) incontinence surgery: results of a prospective study. J Sex Med 2008;5:387-393.
23.
Bekker M, Beck J, Putter H, Venema P, Lycklama à Nijeholt A, Pelger R, Elzevier H: Sexual function improvement following surgery for stress incontinence: the relevance of coital incontinence. J Sex Med 2009;6:3208-3213.
24.
Liang CC, Tseng LH, Lo TS, Lin YH, Lin YJ, Chang SD: Sexual function following outside-in transobturator midurethral sling procedures: a prospective study. Int Urogynecol J 2012;23:1693-1698.
25.
Kim DY, Choi JD: Change of sexual function after midurethral sling procedure for stress urinary incontinence. Int J Urol 2008;15:716-719.
26.
Jha S, Gray T: A systematic review and meta-analysis of the impact of native tissue repair for pelvic organ prolapse on sexual function. Int Urogynecol J 2015;26:321-327.
27.
Berthier A, Sentilhes L, Taibi S, Loisel C, Grise P, Marpeau L: Sexual function in women following the transvaginal tension-free tape procedure for incontinence. Int J Gynaecol Obstet 2008;102:105-109.
28.
Shaw C: A systematic review of the literature on the prevalence of sexual impairment in women with urinary incontinence and the prevalence of urinary leakage during sexual activity. Eur Urol 2002;42:432-440.
29.
Arts-de Jong M, van Altena AM, Aalders CI, Dijkhuizen FP, van Balken MR: Improvement of sexual function after transobturator tape procedure in women with stress urinary incontinence. Gynecol Surg 2011;8:315-319.
30.
Glavind K, Tetsche MS: Sexual function in women before and after suburethral sling operation for stress urinary incontinence: a retrospective questionnaire study. Acta Obstet Gynecol Scand 2004;83:965-968.
31.
Sentilhes L, Berthier A, Loisel C, Descamps P, Marpeau L, Grise P: Female sexual function following surgery for stress urinary incontinence: tension-free vaginal versus transobturator tape procedure. Int Urogynecol J Pelvic Floor Dysfunct 2009;20:393-399.
32.
Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C, Ali H, Young D, Mostafa A: Randomised prospective single-blinded study comparing “inside-out” versus “outside-in” transobturator tapes in the management of urodynamic stress incontinence: 1-year outcomes from the E-TOT study. BJOG 2010;117:870-878.
33.
Ghezzi F, Serati M, Cromi A, Uccella S, Triacca P, Bolis P: Impact of tension-free vaginal tape on sexual function: results of a prospective study. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:54-59.
34.
El-Enen MA, Ragb M, El Gamasy Ael-N, El-Ashry O, El-Sharaby M, Elbadawy A, Fayed N: Sexual function among women with stress incontinence after using transobturator vaginal tape, and its correlation with patient's expectations. BJU Int 2009;104:1118-1123.
35.
Shen T, Song LJ, Xu YM, Gu BJ, Lu LH, Li F: Sexual function and health-related quality of life following anterior vaginal wall surgery for stress urinary incontinence and pelvic organ prolapse. Int J Impot Res 2011;23:151-157.
36.
Fernandes T, Costa-Paiva LH, Pinto-Neto AM: Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial. J Sex Med 2014;11:1262-1270.
37.
Berra M, De Musso F, Matteucci C: The impairment of sexual function is less distressing for menopausal than for premenopausal women. J Sex Med 2010;7:1209-1215.
38.
Delmas V: Anatomical risks of transobturator suburethral tape in the treatment of female stress urinary incontinence. Eur Urol 2005;48:793-798.
39.
Elzevier HW, Putter H, Delaere KP, Venema PL, Lycklama à Nijeholt AA, Pelger RC: Female sexual function after surgery for stress urinary incontinence: transobturator suburethral tape vs. tension-free vaginal tape obturator. J Sex Med 2008;5:400-406.
40.
Schettino MT, Gallo P, Rappa C, Coppola F, Tormettino B, Del Deo F, Grimaldi A, Torella M: Sexual function in patients who underwent surgery for stress urinary incontinence. Minerva Ginecol 2014;66:355-364.
41.
Pastore AL, Palleschi G, Al SY, Riganelli L, Fuschi A, Autieri D, Petrozza V, Carbone A: Evaluation of sexual function and quality of life in women treated for stress urinary incontinence: tension-free transobturator suburethral tape versus single-incision sling. J Women's Health (Larchmt) 2016;25:355-359.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.